Mesoblast | MSB - Des Atouts





Des Atouts Changement Date
Avita Medical AUD 56.39M 1.74M 2025-12
Clinuvel Pharmaceuticals AUD 269.7M 2.05M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Pacific Edge NZD 17.6M 17.06M 2026-06
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Starpharma Holdings AUD 26.17M 746K 2025-12
Telix Pharmaceuticals AUD 1.36B 197.86M 2026-06